STOCK TITAN
  1. Home
  2. Sec-filings
  3. OTLC
  4. [EFFECT] Oncotelic Therapeutics, Inc. SEC Filing

[EFFECT] Oncotelic Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 23, 2025 4:00 P.M.
Form: S-1
CIK: 0000908259
Company Name: Oncotelic Therapeutics, Inc.
File Number: 333-291724

Source: View Original Filing on SEC EDGAR

Stock OTLC logo
Oncotelic Therapeutics Inc

OTC:OTLC

OTLC Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

OTLC Latest News

Dec 22, 2025
Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
Dec 15, 2025
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
Dec 4, 2025
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
Dec 3, 2025
Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
Dec 2, 2025
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

OTLC Latest SEC Filings

Dec 23, 2025
[424B3] Oncotelic Therapeutics, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 23, 2025
[8-K] Oncotelic Therapeutics, Inc. Reports Material Event
Dec 22, 2025
[S-1/A] Oncotelic Therapeutics, Inc. Amends IPO Registration Statement
Dec 9, 2025
[8-K] Oncotelic Therapeutics, Inc. Reports Material Event
Nov 21, 2025
[S-1] Oncotelic Therapeutics, Inc. Files IPO Registration Statement

OTLC Stock Data

21.75M
225.20M
50.55%
2.5%
Biotechnology
Healthcare
Link
United States
Agoura Hills